Rohto, Osaka Univ., and AI Firm to Develop New Solution for Predicting Systemic Diseases from Fundus Data

September 9, 2021
Rohto Pharmaceutical said on September 7 that it has signed a joint research agreement with the Department of Ophthalmology of Osaka University’s Graduate School of Medicine, and the AI analytics company SAI to develop a new solution aimed at promoting...read more